Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 7, 2024 (Week 49)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 13,360 35,866 1,311,782 1,567,394
New England 712 1,111 44,112 51,360
Connecticut 128 296 9,179 12,552
Maine 42 81 2,504 2,825
Massachusetts 400 602 24,980 27,384
New Hampshire 46 73 2,300 2,662
Rhode Island 84 389 4,011 4,693
Vermont 12 33 1,138 1,244
Middle Atlantic 1,608 4,244 170,490 189,739
New Jersey - 748 30,192 33,898
New York (excluding New York City) 882 930 36,761 40,275
New York City - 1,507 55,181 63,706
Pennsylvania 726 1,167 48,356 51,860
East North Central 1,525 4,194 163,654 214,743
Illinois - 1,374 40,104 66,442
Indiana 335 727 29,295 32,230
Michigan 201 876 27,354 40,571
Ohio 618 1,153 45,948 51,789
Wisconsin 371 517 20,953 23,711
West North Central 773 1,987 81,663 92,569
Iowa 143 283 11,177 13,085
Kansas 127 288 10,747 12,716
Minnesota 153 486 18,477 20,684
Missouri 298 648 27,115 29,334
Nebraska - 208 7,452 8,787
North Dakota 51 87 2,859 3,283
South Dakota 1 96 3,836 4,680
South Atlantic 2,917 12,315 323,595 360,117
Delaware - 151 4,659 5,377
District of Columbia 99 180 6,451 7,982
Florida - 6,933 98,514 106,493
Georgia 1,035 1,497 62,187 68,856
Maryland 513 957 29,293 33,990
North Carolina 3 1,437 51,282 62,823
South Carolina 618 1,732 32,169 31,299
Virginia 647 911 35,276 39,118
West Virginia 2 103 3,764 4,179
East South Central 1,051 2,748 56,856 101,923
Alabama 611 884 29,308 31,736
Kentucky 336 592 15,303 15,972
Mississippi 104 1,006 12,245 19,096
Tennessee - 796 - 35,119
West South Central 812 4,647 182,299 213,002
Arkansas 171 399 15,005 16,980
Louisiana 327 749 31,656 34,532
Oklahoma 66 263 10,243 18,489
Texas 248 3,263 125,395 143,001
Mountain 1,244 2,432 97,292 110,100
Arizona 366 833 34,510 39,106
Colorado 468 747 22,673 24,306
Idaho 65 124 4,786 5,501
Montana 36 90 3,119 3,480
Nevada 24 344 13,306 14,948
New Mexico 78 229 8,193 10,526
Utah 187 239 9,411 10,479
Wyoming 20 47 1,294 1,754
Pacific 2,718 4,838 191,821 233,841
Alaska 66 125 4,405 4,861
California 2,061 3,802 157,205 181,937
Hawaii - 101 - 5,971
Oregon 257 354 13,145 14,568
Washington 334 562 17,066 26,504
U.S. Territories - 113 667 4,951
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 113 667 4,951
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 4 53 48
Total 13,361 35,911 1,312,502 1,572,393
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.